Overview

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The results of previous studies suggest further development of [18F]EF5 as a PET tracer for imaging hypoxia. This is a non-randomized prospective study to obtain information on reproducibility of [18F]EF5 intratumor distribution using repeated pretreatment PET/CT scans.
Phase:
Phase 2
Details
Lead Sponsor:
Turku University Hospital